APLM

Apollomics, Inc. APLM

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode APLM CRIS PCSA BCTX HOTH NXTC LNAI LIXT RLYB LSTA
6M 520.14 % 18.46 % 39.09 % -71.72 % 81.46 % 169.30 % -47.37 % 262.90 % 101.85 % 7.02 %
YTD 239.35 % -63.68 % -66.01 % -86.38 % 81.79 % 20.99 % -47.37 % 102.70 % -43.69 % -31.65 %
1Y 167.91 % -71.11 % -78.30 % -90.08 % 59.09 % -25.81 % -47.37 % 134.38 % -51.35 % -18.12 %
3Y -96.39 % -89.19 % -99.18 % -98.65 % -83.29 % -61.62 % -47.37 % -10.00 % -93.31 % -40.92 %
5Y -96.30 % -93.47 % -99.65 % 6 278.51 % -96.89 % -91.32 % -47.37 % -93.53 % -96.20 % -90.49 %
10Y -96.30 % -99.19 % -99.64 % 10 772 727 272 627.27 % -99.34 % -95.00 % -47.37 % -53.13 % -96.20 % -98.78 %
From the beginning -96.30 % -99.94 % -99.91 % 1 814 701 378 154.21 % -99.34 % -95.00 % -47.37 % -99.83 % -96.20 % -100.00 %

Dividend

Lisata Therapeutics, Inc.